Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ØYEPRODUKTER AS
AS
Active
Org 928502546
Stoaveien 9, 4848 Arendal
Retail sale of pharmaceutical products · NACE 4773
Est. 2022
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 225K
-3% vs 2023
EBITDA margin
16.6%
-45% vs 2023
Equity ratio
84.8%
Financial strength
Net profit 2024
NOK 28K
-47% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 225K
-3%
EBITDA
NOK 37K
-45%
Net profit
NOK 28K
-47%
Total assets
NOK 160K
+3%
Equity
NOK 136K
+26%
Employees
0
—
Company information
Legal name
ØYEPRODUKTER AS
Org number
928502546
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
7. januar 2022
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene.
Company purpose
Salg av øyeprodukter og alt som naturlig hører sammen med dette.
Contact
Address
Stoaveien 9, 4848 Arendal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Arendal
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
147
232
225
Staff expenses
−0
−0
−0
EBITDA
31
69
37
Depreciation & amort.
−0
−0
−0
EBIT
31
69
37
Net financials
−0
−0
−1
Profit before tax
31
69
36
Tax
7
15
8
Net profit
24
53
28
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
127
156
160
Equity
54
108
136
Long-term debt
0
0
0
Short-term debt
72
48
24
Total debt
72
48
24
Financial ratios
5-year trend
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
2022
2024
Equity ratio
84.8%
This company
38.2%
Market median
+122% vs market
2022
2024
Return on equity
20.7%
This company
18.4%
Market median
+13% vs market
2022
2024
Net profit margin
12.5%
This company
8.1%
Market median
+54% vs market
2022
2024
Asset turnover
1.40×
This company
1.12×
Market median
+25% vs market
2022
2024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-11-07 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
ST
Siv Tone Johansen
Chairman
2022
TE
Thor Egeberg
Board of Directors
2022
ES
Erlend Sødal
Board of Directors
2022
SJ
Sigmund Jan Birkeland
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Arendal Øyelegesenter As
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Mare Holding As
Arendal Øyelegesenter As
ØYEPRODUKTER AS
(this company)
Board network connections
Board members of ØYEPRODUKTER AS also hold positions in
0
other companies.
Person
Role here
Other companies
Siv Tone Johansen
Chairman
0 companies
Thor Egeberg
Board of Directors
0 companies
Erlend Sødal
Board of Directors
0 companies
Sigmund Jan Birkeland
Board of Directors
0 companies